Skip to main content
See every side of every news story
Published loading...Updated

Dartmouth Health study could point way to sustained weight loss for those who stop using GLP-1 drugs

In the trial, patients switching to orforglipron regained less weight and kept better blood sugar and cholesterol results than those on placebo.

Summary by WMUR
GLP-1 drugs have transformed obesity treatment, but many patients regain weight after stopping the medication. A new study could point the way to a solution.

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

WMUR broke the news in New Hampshire, United States on Wednesday, May 20, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal